{"id":95908,"date":"2024-06-27T09:18:36","date_gmt":"2024-06-27T09:18:36","guid":{"rendered":"https:\/\/www.mymsd.ch\/fr\/?p=95908"},"modified":"2026-03-02T15:02:45","modified_gmt":"2026-03-02T15:02:45","slug":"nouvelles-therapies-pour-les-tumeurs-gastro-intestinales","status":"publish","type":"post","link":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/","title":{"rendered":"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" height=\"313\" width=\"1024\" src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?w=1024\" alt=\"digestive system banner\" class=\"wp-image-95905\" srcset=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg 5000w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=300,92 300w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=768,235 768w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=1024,313 1024w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=1536,470 1536w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=2048,626 2048w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=320,98 320w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=120,37 120w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR-1.jpg?resize=1400,428 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--d88d15aa0c820b7e5c969dfbc862e00e mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--0eb141d6a7d29770d1a3788309ac6a46 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<h3 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color has-teal-500-color has-text-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--41cfe08d6cf37bb9b674b7ed59c1c66d\">Swissmedic a approuv\u00e9 trois autres th\u00e9rapies avec KEYTRUDA\u00ae pour les tumeurs gastro-intestinales<sup>1<\/sup><\/h3>\n\n\n\n<h4 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--21dc91791290aa7da1beec37c36cef7c\">D\u00e9sormais, KEYTRUDA\u00ae est \u00e0 votre disposition ainsi que pour vos patient:es comme suit:<\/h4>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-columns--align-center mhh-mcn-columns--vertical-alignment-top mhh-mcn-v1-columns--809b56e21417c2ec3c15530aaf070670 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--e58b53d5d53f8c906add0c5a2c770de6 mhh-mcn-column mhh-mcn-column--7 mhh-mcn-column--m-3 mhh-mcn-column--l-3\">\n    \n<figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--align-center mhh-mcn-v1-image--d128ba9830ba0b6507236bd85fabaef1\">\n                <a\n        class=\"mhh-mcn-anchor-for-image\"\n        href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/gastric\/\"\n        rel=\"noreferrer noopener\"\n        target=\"_blank\"\n    >\n            <img loading=\"lazy\" decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--thumbnail wp-image-95376\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/05\/Karzinom-des-Magens1.png?w=150&#038;h=150&#038;crop=1&#038;quality=80&#038;lossy=1\"\n        width=\"150\"\n        height=\"150\"\n                alt=\"stomach icon\"\n            \/>\n        <\/a>\n        <\/figure>\n\n<\/div>\n\n\n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--5a56a9dd65a614836ef0d73f8ba17837 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-9 mhh-mcn-column--l-9\">\n    \n\n<h4 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--5426b2ba5b87064ae6260047acb21fd3\"><strong><mark class=\"has-inline-color has-teal-500-color\"><a href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/gastric\/\" target=\"_blank\" rel=\"noreferrer noopener\">NOUVEAU: Carcinome gastrique\/de la JOG<\/a><\/mark><\/strong><\/h4>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--779c7f74e0b725e5ee18e5115a0d0358 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--27e6973e119c3adb519e0529b5afa274 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--f5509daa99a836f2f74ca86f00d0cd26 wp-block-paragraph\"><strong>1L th\u00e9rapie combin\u00e9e dans l&rsquo;ad\u00e9nocarcinome HER2-positif avanc\u00e9 de l&rsquo;estomac\/de la JOG<\/strong> KEYTRUDA\u00ae en association avec le trastuzumab, une chimioth\u00e9rapie \u00e0 base de fluoropyrimidine et de platine, est indiqu\u00e9 dans le traitement de premi\u00e8re ligne chez les adultes atteints d&rsquo;un ad\u00e9nocarcinome gastrique ou de la jonction \u0153sogastrique (JOG) localement avanc\u00e9, non r\u00e9s\u00e9cable ou m\u00e9tastatique, HER2-positif, dont les tumeurs expriment PD-L1 avec un CPS \u22651.<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--28c4a368520a153563d08f292c5aea42\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--d4e486609cf606143393f8477f40a5ef\" href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/gastric\/kn811\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Indication Keytruda Cancer gastrique (KN811)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Vers l&rsquo;\u00e9tude KEYNOTE-811<sup>2<\/sup><\/span>\n                <\/a><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:24px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--82a04eddbac97f24aa9ea34094690ab9 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--67525bc2b8f6bec9e36557594ba6d997 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--6dc7937dbbeca97197cf82786946157e wp-block-paragraph\"><strong>1L <strong><strong>th\u00e9rapie combin\u00e9e dans l&rsquo;ad\u00e9nocarcinome HER2-n\u00e9gatif avanc\u00e9 de l&rsquo;estomac\/de la JOG<\/strong><\/strong><\/strong> KEYTRUDA\u00ae en association \u00e0 une chimioth\u00e9rapie \u00e0 base de fluoropyrimidine et de platine est indiqu\u00e9 dans le traitement de premi\u00e8re ligne chez les adultes atteints d\u2019un ad\u00e9nocarcinome gastrique ou de la jonction \u0153sogastrique, localement avanc\u00e9, non r\u00e9s\u00e9cable ou m\u00e9tastatique, HER2-n\u00e9gatif, dont les tumeurs expriment PD-L1 avec un CPS \u22651.<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--4ff1598e04f8fdd9adef087cc63638a8\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--17ffb1b3e524bfbad1516cc734730b8b\" href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/gastric\/kn859\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Indication Keytruda Cancer gastrique (KN859)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Vers l&rsquo;\u00e9tude KEYNOTE-859<sup>3<\/sup><\/span>\n                <\/a><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-columns--align-center mhh-mcn-columns--vertical-alignment-top mhh-mcn-v1-columns--4563f945d0faff62046a4825d411f981 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--e6292ac046defb91a9ed44005d16f0ab mhh-mcn-column mhh-mcn-column--7 mhh-mcn-column--m-3 mhh-mcn-column--l-3\">\n    \n<figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--align-center mhh-mcn-v1-image--bd3f4606d84576be01e361396fb6b850\">\n                    <img decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--thumbnail wp-image-95158\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/05\/Gallengangskarzinom.png?w=150&#038;h=150&#038;crop=1&#038;quality=80&#038;lossy=1\"\n        width=\"150\"\n        height=\"150\"\n        loading=\"lazy\"        alt=\"liver with bile ducts icon\"\n            \/>\n            <\/figure>\n\n<\/div>\n\n\n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--da75b02e3be44a08fa402792ea0c09e0 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-9 mhh-mcn-column--l-9\">\n    \n\n<h4 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--9d864e19f4ad5abe307a65bc35d23553\"><strong><mark class=\"has-inline-color has-teal-500-color\">NOUVEAU: Cancer des voies biliaires<\/mark><\/strong><\/h4>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--41ff887294fd9b6babcb23f0ddde0c9f mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--68a924b1692aaf45ffa14b81b3bb679b mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--4e74f5117d30011247fd770e03336395 wp-block-paragraph\"><strong>1L <strong><strong>th\u00e9rapie combin\u00e9e <\/strong><\/strong><\/strong>KEYTRUDA\u00ae, en association \u00e0 la gemcitabine et au cisplatine, est indiqu\u00e9 dans le traitement de premi\u00e8re ligne des patients adultes atteints d\u2019un carcinome des voies biliaires (CVB) localement avanc\u00e9 non r\u00e9s\u00e9cable ou m\u00e9tastatique.<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--1672894249a077e3be2771d28f61b285\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--78d64c94966bfa82856bb9fd15f14dc1\" href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/kn966\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Indication Keytruda Cancer gastrique (KN966)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Vers l&rsquo;\u00e9tude KEYNOTE-966<sup>4<\/sup><span><\/span><\/span>\n                <\/a><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-columns--align-center mhh-mcn-columns--vertical-alignment-top mhh-mcn-v1-columns--f20136333697f2ab5643b826165bc33d mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--a8eb109cd4d74ec13fc3808562465554 mhh-mcn-column mhh-mcn-column--7 mhh-mcn-column--m-3 mhh-mcn-column--l-3\">\n    \n<figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--align-center mhh-mcn-v1-image--dd009d1f322f358aaaa18676aedd4b2b\">\n                <a\n        class=\"mhh-mcn-anchor-for-image\"\n        href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/colorectal\/\"\n        rel=\"noreferrer noopener\"\n        target=\"_blank\"\n    >\n            <img decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--thumbnail wp-image-95218\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/05\/Kolorektales-Karzinom.png?w=150&#038;h=150&#038;crop=1&#038;quality=80&#038;lossy=1\"\n        width=\"150\"\n        height=\"150\"\n        loading=\"lazy\"        alt=\"large intestine icon\"\n            \/>\n        <\/a>\n        <\/figure>\n\n<\/div>\n\n\n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--7cc42e40f8fb1ebe251a92e2abf4355b mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-9 mhh-mcn-column--l-9\">\n    \n\n<h4 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--678a0a2d33ce94d8c81e8e042a611431\"><strong><mark class=\"has-inline-color has-teal-500-color\"><a href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/colorectal\/\" target=\"_blank\" rel=\"noreferrer noopener\">Carcinome colorectal avec MSI-H\/dMMR<\/a><\/mark><\/strong><\/h4>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--489d0f9415432b7b89c7f37e4e5d4749 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--652ea3187c02e71756eedf5cd2bfb084 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--e6ad4507dcc330156ef68072cc4f777b wp-block-paragraph\"><strong>1L monoth\u00e9rapie<\/strong> KEYTRUDA\u00ae en monoth\u00e9rapie est indiqu\u00e9 dans le traitement de premi\u00e8re ligne des patients adultes atteints d&rsquo;un cancer colorectal (CRC) m\u00e9tastatique pr\u00e9sentant une forte instabilit\u00e9 microsatellitaire (MSI-H) ou une d\u00e9ficience du syst\u00e8me de r\u00e9paration des m\u00e9sappariements de l&rsquo;ADN (dMMR).<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--7f189e60d8f0cfba76b5edc6991730ad\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--07f822e7f681c70571e96598a80cb464\" href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/colorectal\/kn177\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Indication Keytruda Cancer colorectal (KN177)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Vers l&rsquo;\u00e9tude KEYNOTE-177<sup>5<\/sup><\/span>\n                <\/a><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:24px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--e8c90ede6bb9eed96d30905a4a667279 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--efcdd30825a39ca7cf8b90bf10f7b85b mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--81a4b9d091d7fcf391dab8cf13f1cb02 wp-block-paragraph\"><strong>2L <strong>monoth\u00e9rapie<\/strong><\/strong> KEYTRUDA\u00ae en monoth\u00e9rapie est indiqu\u00e9 dans le traitement des patients adultes atteints d&rsquo;un cancer colorectal (CRC) non r\u00e9s\u00e9cable ou m\u00e9tastatique pr\u00e9sentant une forte instabilit\u00e9 microsatellitaire (MSI-H) ou une d\u00e9ficience du syst\u00e8me de r\u00e9paration des m\u00e9sappariements de l&rsquo;ADN (deficient DNA Mismatch Repair, dMMR) qui ont re\u00e7u un traitement ant\u00e9rieur \u00e0 base de fluoropyrimidine en association avec de l&rsquo;irinot\u00e9can ou de l&rsquo;oxaliplatine.<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--bd204fbae9f9c85e64eb6ede6213f3b2\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--116aae45b064bdc9ae7bed3867b8017e\" href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/colorectal\/kn164\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Indication Keytruda Cancer colorectal (KN164)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Vers l&rsquo;\u00e9tude KEYNOTE-164<sup>6<\/sup><\/span>\n                <\/a><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-columns--align-center mhh-mcn-columns--vertical-alignment-top mhh-mcn-v1-columns--41ac6c22bba7efc85aa70edcb1bb3727 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--dfa9d80d13ab1bad28cfbc39da58b298 mhh-mcn-column mhh-mcn-column--7 mhh-mcn-column--m-3 mhh-mcn-column--l-3\">\n    \n<figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--align-center mhh-mcn-v1-image--2467e1d0e9e6aaeb1f3ed550df0f4c84\">\n                    <img decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--thumbnail wp-image-95189\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/05\/MSI-H-oder-dMMR.png?w=150&#038;h=150&#038;crop=1&#038;quality=80&#038;lossy=1\"\n        width=\"150\"\n        height=\"150\"\n        loading=\"lazy\"        alt=\"MSI-H-oder-dMMR\"\n            \/>\n            <\/figure>\n\n<\/div>\n\n\n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--e7df785e57e54de705baef25e8869b86 mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-9 mhh-mcn-column--l-9\">\n    \n\n<h4 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--689a1287ad1cfdf2c33afcf623a448d7\"><strong><mark class=\"has-inline-color has-teal-500-color\">Cancer de l&rsquo;estomac, de l&rsquo;intestin gr\u00eale ou des voies biliaires avec MSI-H ou dMMR<\/mark><\/strong><\/h4>\n\n\n<div class=\"mhh-mcn-columns mhh-mcn-v1-columns--7b3c23faf5d094891131727d4618204c mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        \n<div class=\"mhh-mcn-v1-column mhh-mcn-v1-column--21597bd79f9f6b4e773cd1a89d03f50c mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-12 mhh-mcn-column--l-12\">\n    \n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--bc9168d16f072fef8b7257a5ac217b2b wp-block-paragraph\"><strong>2L+ <strong>monoth\u00e9rapie<\/strong><\/strong> KEYTRUDA\u00ae en monoth\u00e9rapie est indiqu\u00e9 dans le traitement des patients adultes atteints d&rsquo;un cancer m\u00e9tastatique de l&rsquo;estomac, de l&rsquo;intestin gr\u00eale ou des voies biliaires, avec une instabilit\u00e9 \u00e9lev\u00e9e des microsatellites (MSI-H) ou une r\u00e9paration d\u00e9fectueuse des m\u00e9sappariements de l&rsquo;ADN (dMMR), ayant progress\u00e9 apr\u00e8s le traitement standard et pour lesquels il n&rsquo;existe pas d&rsquo;alternatives th\u00e9rapeutiques satisfaisantes.<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--7f4976a67c95e5d24f1e00c561a5ce55\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--be07097777bf38f7433c68932d139c32\" href=\"https:\/\/www.mymsd.ch\/fr\/products\/keytruda\/indications\/gastrointestinal-cancers\/kn158\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Indication Keytruda Cancer gastro-intestinal (KN158)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Vers l&rsquo;\u00e9tude KEYNOTE-158<sup>7<\/sup><\/span>\n                <\/a><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--eb47e32340364618e6ceff97a5859384\">Le portefeuille de KEYTRUDA\u00ae cro\u00eet constamment<\/h4>\n\n\n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--ab6827140b2f06b9837fda00603b6c25 wp-block-paragraph\">Chez MSD, nous travaillons sans rel\u00e2che pour mettre \u00e0 disposition des th\u00e9rapies qui offrent aux patient:es atteint:es du cancer une meilleure qualit\u00e9 de vie et plus de temps. <strong>D\u00e9sormais, vous et vos patient:es disposez de six options th\u00e9rapeutiques avec KEYTRUDA\u00ae pour le traitement des tumeurs gastro-intestinales.<\/strong><\/p>\n\n\n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--ca9408f24700dcef6e77205ead78fc81 wp-block-paragraph\">Veuillez noter que le remboursement par les caisses-maladie pour les nouvelles indications approuv\u00e9es est encore en attente. L&rsquo;inscription sur la liste des sp\u00e9cialit\u00e9s (LS) de l&rsquo;Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP) constitue pour nous une priorit\u00e9.<\/p>\n\n\n\n<div style=\"height:22px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<\/div>\n\n    <\/div>\n\n    <\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\r\n<div class=\"inpsyde-iframe is-responsive has-transparent-background-color\">\r\n    <iframe loading=\"lazy\" height=\"400\" referrerpolicy=\"no-referrer-when-downgrade\" title=\"Ce contenu vous a-t-il \u00e9t\u00e9 pertinent ?\" src=\"https:\/\/go.screver.com\/msd-ch-cx\/newsroom-articles?lang=fr&amp;hideHeader=true\" width=\"100%\"><\/iframe>\r\n<\/div>\n\n\n<section class=\"mhh-mcn-v1-section mhh-mcn-v1-section--6e570ff97dc542c9fe647b1fc8c44d54 mhh-mcn-section mhh-mcn-v1-section--align-full\">\n    <div class=\"mhh-mcn-container\">\n    \n\n<h3 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color has-text-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--e94657ebad452fee692fbe855d3bd372\" style=\"color:#000000\">Related Content<\/h3>\n\n\n<div class=\"mhh-mcn-v1-content-items mhh-mcn-v1-content-items--10a524f709860531a891097cef5914ea wp-block-mconnect-theme-curated-content mhh-mcn-layout--columns mhh-mcn-columns mhh-mcn-v1-columns--80b7504ceb4d2f2d1fe2cea448356110 mhh-mcn-v1-columns mhh-mcn-columns--gutter-m\">\n    <div class=\"mhh-mcn-columns-inner\">\n        <div\n    class=\"mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-6 mhh-mcn-column--l-4 mhh-mcn-v1-content-item mhh-mcn-v1-content-item--86a6a5dba8dd0ca4c966fd2fae09d4ca mhh-mcn-v1-content-item--type-post mhh-mcn-v1-content-item--card-style mhh-mcn-v1-content-item--display-media-style mhh-mcn-v1-content-item--has-featured-image\">\n    <div class=\"mhh-mcn-v1-content-item-featured-image\">\n    <figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--a2dc4f9f210ee4f984d13f1b049ec701 with-aspect-ratio with-aspect-ratio--content-grid\">\n    <div class=\"figure-outer\">\n    <div class=\"figure-inner\">\n                            <img decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--2048x2048 wp-image-47855\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/hero_empathy-white_lo_96dpi.jpg?w=1280&#038;quality=80&#038;lossy=1\"\n        width=\"1280\"\n        height=\"720\"\n        loading=\"lazy\"        alt=\"\"\n            \/>\n                <\/div>\n    <\/div>\n    <\/figure>\n<\/div>\n\n<article class=\"mhh-mcn-v1-content-item-content\">\n    <section class=\"mhh-mcn-v1-content-item-content-body\">\n        \n<span class=\"mhh-mcn-v1-content-item-primary-tag mhh-mcn-v1-content-item-primary-tag--c06ec76831703497d2b89abb588910eb\" title=\"This item has been tagged as: MSD Services\">\n    MSD Services<\/span>\n        <header class=\"mhh-mcn-v1-content-item-header\">\n    \n    <span class=\"mhh-mcn-v1-content-item-icon-type mhh-mcn-v1-content-item-icon-type--post\">\n    <span class=\"mhh-mcn-v1-content-item-icon-type__icon\">\n    \n<svg width=\"1em\" height=\"1em\" class=\"mh-icon mh-icon--kind-generic mh-icon--name-arrow-right mh-icon--arrow-right\" role=\"img\" aria-hidden=\"true\">\n    \n    \n    <use xlink:href=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/themes\/cex-wpvip-mhh-mconnect-theme-new-3.0\/modules\/icons\/resources\/icons\/svg\/generic\/arrow-right.svg#arrow-right\"><\/use>\n<\/svg>\n    <\/span>\n    <\/span>\n    <h2 class=\"mhh-mcn-v1-content-item-title mhh-mcn-v1-content-item-title--c06ec76831703497d2b89abb588910eb\">\n    \n    <a class=\"mhh-mcn-v1-content-item-title__link\" href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/formulaires-de-demande-de-prise-en-charge-de-keytruda\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n        Utilisez-vous d\u00e9j\u00e0 les formulaires de demande de prise en charge de KEYTRUDA\u00ae?    <\/a>\n    <\/h2>\n\n    <\/header>\n\n        <p class=\"mhh-mcn-v1-content-item-excerpt mhh-mcn-v1-content-item-excerpt--c06ec76831703497d2b89abb588910eb\">\n    En raison de l\u2019augmentation constante du nombre d\u2019indications de KEYTRUDA\u00ae autoris\u00e9es par Swissmedic, il est difficile de savoir quelles indications sont rembours\u00e9es et si des limitations suppl\u00e9mentaires de la liste des sp\u00e9cialit\u00e9s doivent \u00eatre prises en compte.<\/p>\n        \n<div class=\"mhh-mcn-v1-content-item-meta mhh-mcn-badge-container\">\n    \n    \n    <\/div>\n    <\/section>\n    <div class=\"mhh-mcn-v1-content-item-footer\">\n    \n    <div class=\"mhh-mcn-v1-content-item-call-to-action mhh-mcn-v1-content-item-call-to-action--c06ec76831703497d2b89abb588910eb\">\n    En savoir plus<\/div>\n\n    <\/div>\n<\/article>\n<\/div>\n<div\n    class=\"mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-6 mhh-mcn-column--l-4 mhh-mcn-v1-content-item mhh-mcn-v1-content-item--9ea8364b442c72f1c4b03975203bdfff mhh-mcn-v1-content-item--type-post mhh-mcn-v1-content-item--card-style mhh-mcn-v1-content-item--display-media-style mhh-mcn-v1-content-item--has-featured-image\">\n    <div class=\"mhh-mcn-v1-content-item-featured-image\">\n    <figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--cb236f534dedd7426358f1bfa47ba7d5 with-aspect-ratio with-aspect-ratio--content-grid\">\n    <div class=\"figure-outer\">\n    <div class=\"figure-inner\">\n                            <img decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--2048x2048 wp-image-67182\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/keytruda-ch_Nouveau-site-web_S.png?w=635&#038;quality=80&#038;lossy=1\"\n        width=\"635\"\n        height=\"475\"\n        loading=\"lazy\"        alt=\"\"\n            \/>\n                <\/div>\n    <\/div>\n    <\/figure>\n<\/div>\n\n<article class=\"mhh-mcn-v1-content-item-content\">\n    <section class=\"mhh-mcn-v1-content-item-content-body\">\n        \n<span class=\"mhh-mcn-v1-content-item-primary-tag mhh-mcn-v1-content-item-primary-tag--c06ec76831703497d2b89abb588910eb\" title=\"This item has been tagged as: Patienten Services\">\n    Patienten Services<\/span>\n        <header class=\"mhh-mcn-v1-content-item-header\">\n    \n    <span class=\"mhh-mcn-v1-content-item-icon-type mhh-mcn-v1-content-item-icon-type--post\">\n    <span class=\"mhh-mcn-v1-content-item-icon-type__icon\">\n    \n<svg width=\"1em\" height=\"1em\" class=\"mh-icon mh-icon--kind-generic mh-icon--name-arrow-right mh-icon--arrow-right\" role=\"img\" aria-hidden=\"true\">\n    \n    \n    <use xlink:href=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/themes\/cex-wpvip-mhh-mconnect-theme-new-3.0\/modules\/icons\/resources\/icons\/svg\/generic\/arrow-right.svg#arrow-right\"><\/use>\n<\/svg>\n    <\/span>\n    <\/span>\n    <h2 class=\"mhh-mcn-v1-content-item-title mhh-mcn-v1-content-item-title--c06ec76831703497d2b89abb588910eb\">\n    \n    <a class=\"mhh-mcn-v1-content-item-title__link\" href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/site-web-pour-vos-patientes-et-patients-recevant-keytruda\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n        keytruda.ch \u2013 Site web pour vos patientes et patients recevant KEYTRUDA\u00ae    <\/a>\n    <\/h2>\n\n    <\/header>\n\n        <p class=\"mhh-mcn-v1-content-item-excerpt mhh-mcn-v1-content-item-excerpt--c06ec76831703497d2b89abb588910eb\">\n    Le traitement du cancer peut \u00eatre tr\u00e8s complexe. Toute nouvelle th\u00e9rapie peut susciter des questions, des craintes et des incertitudes. Le site web keytruda.ch pour les patientes et patients vise \u00e0 r\u00e9pondre \u00e0 la demande d\u2019informations et de conseils. Il r\u00e9sume, dans un langage simple et compr\u00e9hensible, les connaissances essentielles relatives au traitement par KEYTRUDA\u00ae.\n<\/p>\n        \n<div class=\"mhh-mcn-v1-content-item-meta mhh-mcn-badge-container\">\n    \n    \n    <\/div>\n    <\/section>\n    <div class=\"mhh-mcn-v1-content-item-footer\">\n    \n    <div class=\"mhh-mcn-v1-content-item-call-to-action mhh-mcn-v1-content-item-call-to-action--c06ec76831703497d2b89abb588910eb\">\n    En savoir plus<\/div>\n\n    <\/div>\n<\/article>\n<\/div>\n<div\n    class=\"mhh-mcn-column mhh-mcn-column--12 mhh-mcn-column--m-6 mhh-mcn-column--l-4 mhh-mcn-v1-content-item mhh-mcn-v1-content-item--deef0d91c1649b5a591eeeffd6f2b6cd mhh-mcn-v1-content-item--type-post mhh-mcn-v1-content-item--card-style mhh-mcn-v1-content-item--display-media-style mhh-mcn-v1-content-item--has-featured-image\">\n    <div class=\"mhh-mcn-v1-content-item-featured-image\">\n    <figure class=\"mhh-mcn-v1-image mhh-mcn-v1-image--f7a4c03c0534233255f1ea6455ec01cc with-aspect-ratio with-aspect-ratio--content-grid\">\n    <div class=\"figure-outer\">\n    <div class=\"figure-inner\">\n                            <img decoding=\"async\"\n        class=\"mhh-mcn-image mhh-mcn-image--2048x2048 wp-image-77928\"\n        src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/03\/article_5_march-thumb-1.png?w=1270&#038;quality=80&#038;lossy=1\"\n        width=\"1270\"\n        height=\"894\"\n        loading=\"lazy\"        alt=\"\"\n            \/>\n                <\/div>\n    <\/div>\n    <\/figure>\n<\/div>\n\n<article class=\"mhh-mcn-v1-content-item-content\">\n    <section class=\"mhh-mcn-v1-content-item-content-body\">\n        \n<span class=\"mhh-mcn-v1-content-item-primary-tag mhh-mcn-v1-content-item-primary-tag--c06ec76831703497d2b89abb588910eb\" title=\"This item has been tagged as: Enqu\u00eate\">\n    Enqu\u00eate<\/span>\n        <header class=\"mhh-mcn-v1-content-item-header\">\n    \n    <span class=\"mhh-mcn-v1-content-item-icon-type mhh-mcn-v1-content-item-icon-type--post\">\n    <span class=\"mhh-mcn-v1-content-item-icon-type__icon\">\n    \n<svg width=\"1em\" height=\"1em\" class=\"mh-icon mh-icon--kind-generic mh-icon--name-arrow-right mh-icon--arrow-right\" role=\"img\" aria-hidden=\"true\">\n    \n    \n    <use xlink:href=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/themes\/cex-wpvip-mhh-mconnect-theme-new-3.0\/modules\/icons\/resources\/icons\/svg\/generic\/arrow-right.svg#arrow-right\"><\/use>\n<\/svg>\n    <\/span>\n    <\/span>\n    <h2 class=\"mhh-mcn-v1-content-item-title mhh-mcn-v1-content-item-title--c06ec76831703497d2b89abb588910eb\">\n    \n    <a class=\"mhh-mcn-v1-content-item-title__link\" href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/barometre-suisse-du-cancer-2023\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n        Barom\u00e8tre suisse des soins contre le cancer: une coordination accrue est souhait\u00e9e    <\/a>\n    <\/h2>\n\n    <\/header>\n\n        <p class=\"mhh-mcn-v1-content-item-excerpt mhh-mcn-v1-content-item-excerpt--c06ec76831703497d2b89abb588910eb\">\n    R\u00e9sultats de l&rsquo;enqu\u00eate repr\u00e9sentative de l\u2019institut de recherche gfs.bern sur la qualit\u00e9 de la prise en charge du cancer en Suisse: Les sujets du d\u00e9pistage et du traitement pr\u00e9coces du cancer sont les plus importants pour les personnes interrog\u00e9es.<\/p>\n        \n<div class=\"mhh-mcn-v1-content-item-meta mhh-mcn-badge-container\">\n    \n    \n    <\/div>\n    <\/section>\n    <div class=\"mhh-mcn-v1-content-item-footer\">\n    \n    <div class=\"mhh-mcn-v1-content-item-call-to-action mhh-mcn-v1-content-item-call-to-action--c06ec76831703497d2b89abb588910eb\">\n    En savoir plus<\/div>\n\n    <\/div>\n<\/article>\n<\/div>\n    <\/div>\n\n    <\/div>\n\n    <\/div>\n<\/section>\n\n\n\n<h5 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--f500ff0afdc6269a076af5d200225cc1\"><strong>Abr\u00e9viations<\/strong><em>:<\/em><\/h5>\n\n\n\n<p class=\"has-object-object-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--618f5785247ae0ce995b2983303b6847 wp-block-paragraph\"><strong>CPS<\/strong>: combined positive Score (score combin\u00e9 positif); <strong>CVB<\/strong>: cancer des voies biliaires; <strong>HER2<\/strong>: Human Epidermal Growth Factor Receptor-2 (r\u00e9cepteur 2 au facteur de croissance \u00e9pidermique); <strong>JOG<\/strong>: jonction \u0153sogastrique; <strong>NCCN<\/strong>: National Comprehensive Cancer Network; <strong>PD-L1<\/strong>: Programmed Death-Ligand 1 (ligand 1 de la mort cellulaire programm\u00e9e).<\/p>\n\n\n\n<h5 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--aa09b791b15be59a0e8dc65845d65c69\"><strong>R\u00e9f\u00e9rences:<\/strong><\/h5>\n\n\n\n<ol class=\"mhh-mcn-v2-clist mhh-mcn-v2-clist--463f4805023db7f9deb72d030ae9be0b mhh-mcn-list mhh-mcn-v2-clist--ordered mhh-mcn-v2-clist--ordered-decimal\" dir=\"ltr\" lang=\"fr-FR\" start=\"1\">\n    \n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Information professionnelle de KEYTRUDA\u00ae, <a href=\"https:\/\/www.swissmedicinfo-pro.ch\/showText.aspx?textType=FI&amp;lang=FR&amp;authNr=66231&amp;supportMultipleResults=1\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo-pro.ch<\/a>.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Janjigian YY, et al. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial. Lancet 2023;402:2197\u2013208.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Rha SY, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24:1181\u201395.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853 \u2013 1865.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Diaz LA, Shiu K-K, Kim T-W, et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022;23(5):P659 \u2013 670. With supplement appendix.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Le DT, Kim TW, Van Cutsem E, et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability\u2013high\/mismatch repair\u2013deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol. 2020;38(1):11\u201319.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Marabelle A, Le DT, Ascierto PA, et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair\u2013deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2019;38(1):1\u201314.    <\/li>\n\n<\/ol>\n\n\n\n<p class=\"has-object-object-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--664ef237b727a3ffee8656aef3ebcdd6 wp-block-paragraph\">Des exemplaires des publications de l\u2019\u00e9tude peuvent \u00eatre demand\u00e9s \u00e0 <a href=\"mailto:dpoc.switzerland@msd.com\">dpoc.switzerland@msd.com<\/a> si n\u00e9cessaire.<\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--f14a0c10ee793d96bb5be434e5bfaa28\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--fb56b74cd917c8f59d04daa5762a0061 mhh-mcn-v1-link--is-variation mhh-mcn-v1-link--button-primary\" href=\"https:\/\/www.swissmedicinfo-pro.ch\/showText.aspx?textType=FI&#038;lang=FR&#038;authNr=66231&#038;supportMultipleResults=1\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Information professionnelle de KEYTRUDA\u00ae\">\n                    <span class=\"mhh-mcn-v1-link__label\">Information professionnelle de KEYTRUDA\u00ae<\/span>\n                <\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Swissmedic a approuv\u00e9 trois autres th\u00e9rapies avec KEYTRUDA\u00ae pour les tumeurs gastro-intestinales.<\/p>\n","protected":false},"author":202221,"featured_media":95901,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mhh_sticky_footer_settings":{"entityId":0},"_mhh_sticky_footer_posts":"","_mhh_sticky_footer_expanded":false,"_mhh_mcn_text_direction":"","_mhh_mcn_language":"","_mhh_mcn_left_sidebar_settings":{"entityId":0},"_mhh_mcn_sidebar_settings":{"entityId":0},"mhh_mcn_side_navigation_style":{"fontSize":{"l":"","m":"","s":""},"lineHeight":{"l":1.5,"m":1.5,"s":1.5},"itemColor":"","hoverItemColor":"","currentItemColor":"","borderItemColor":"","backgroundItemHoverColor":"","themeColor":""},"_mhh_mcn_child_page_navigation":{"isActive":false,"isSticky":false},"hide_header":false,"show_top_bar":false,"hide_footer":false,"full_width_layout":false,"icon":null,"job_code":"","hide_featured_image":true,"primary_tag":1606,"editor_notices":[],"mconnectHideShareThis":false,"footnotes":"","sidebar_toogle":0,"sidebar_toogle_notification_warning":true,"sidebar_toogle_notification_alert":true,"content_expiration_sidebar_date":"","content_expiration_sidebar_expired_post_status":"","content_expiration_sidebar_redirection":""},"categories":[792,791],"tags":[1606],"ga4_page_audience":[],"ga4_page_birn_id":[],"ga4_page_branding":[957],"ga4_page_businessunit":[963],"ga4_page_campaign":[],"ga4_page_content_purpose":[],"ga4_page_customer_journey_stage":[],"ga4_page_customer_specialty":[],"ga4_page_experience":[],"ga4_page_indication":[],"ga4_page_material_intent":[1206],"ga4_page_product":[],"ga4_page_region":[],"ga4_page_therapeuticarea":[],"tx-therapeutic-area":[627,931],"tx-product":[642],"tx-pathology":[1605],"tx-content-type":[795],"tx-active-ingredient":[],"access":[],"user_status":[4],"user_role":[],"class_list":["post-95908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-onco-news","category-oncology","tag-tumeurs-gastro-intestinales"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales - MyMSD.ch FR Onco News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales - MyMSD.ch FR Onco News\" \/>\n<meta property=\"og:description\" content=\"Swissmedic a approuv\u00e9 trois autres th\u00e9rapies avec KEYTRUDA\u00ae pour les tumeurs gastro-intestinales.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/\" \/>\n<meta property=\"og:site_name\" content=\"MyMSD.ch FR\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-27T09:18:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:02:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2646\" \/>\n\t<meta property=\"og:image:height\" content=\"1979\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MDM\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"MDM\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/\"},\"author\":{\"name\":\"MDM\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#\\\/schema\\\/person\\\/5582d9c89a597dff94818e6008b86ab7\"},\"headline\":\"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales\",\"datePublished\":\"2024-06-27T09:18:36+00:00\",\"dateModified\":\"2026-03-02T15:02:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/\"},\"wordCount\":634,\"publisher\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2024\\\/06\\\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg\",\"keywords\":[\"Tumeurs gastro-intestinales\"],\"articleSection\":[\"Onco News\",\"Oncology\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/\",\"name\":\"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales - MyMSD.ch FR Onco News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2024\\\/06\\\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg\",\"datePublished\":\"2024-06-27T09:18:36+00:00\",\"dateModified\":\"2026-03-02T15:02:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2024\\\/06\\\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2024\\\/06\\\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg\",\"width\":2646,\"height\":1979},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/oncology\\\/onco-news\\\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/\",\"name\":\"MyMSD.ch FR\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#organization\",\"name\":\"MSD Switzerland\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2026\\\/11\\\/MSD-Logo-square.png\",\"contentUrl\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2026\\\/11\\\/MSD-Logo-square.png\",\"width\":500,\"height\":500,\"caption\":\"MSD Switzerland\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/#\\\/schema\\\/person\\\/5582d9c89a597dff94818e6008b86ab7\",\"name\":\"MDM\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44e333b8caf35634006075d37ca161c6c10595fef18dfb504ce1f84b93d105fe?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44e333b8caf35634006075d37ca161c6c10595fef18dfb504ce1f84b93d105fe?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44e333b8caf35634006075d37ca161c6c10595fef18dfb504ce1f84b93d105fe?s=96&d=mm&r=g\",\"caption\":\"MDM\"},\"url\":\"https:\\\/\\\/www.mymsd.ch\\\/fr\\\/author\\\/mdalmolin1\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales - MyMSD.ch FR Onco News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/","og_locale":"fr_FR","og_type":"article","og_title":"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales - MyMSD.ch FR Onco News","og_description":"Swissmedic a approuv\u00e9 trois autres th\u00e9rapies avec KEYTRUDA\u00ae pour les tumeurs gastro-intestinales.","og_url":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/","og_site_name":"MyMSD.ch FR","article_published_time":"2024-06-27T09:18:36+00:00","article_modified_time":"2026-03-02T15:02:45+00:00","og_image":[{"width":2646,"height":1979,"url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg","type":"image\/jpeg"}],"author":"MDM","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"MDM","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#article","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/"},"author":{"name":"MDM","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/5582d9c89a597dff94818e6008b86ab7"},"headline":"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales","datePublished":"2024-06-27T09:18:36+00:00","dateModified":"2026-03-02T15:02:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/"},"wordCount":634,"publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg","keywords":["Tumeurs gastro-intestinales"],"articleSection":["Onco News","Oncology"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/","url":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/","name":"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales - MyMSD.ch FR Onco News","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#primaryimage"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg","datePublished":"2024-06-27T09:18:36+00:00","dateModified":"2026-03-02T15:02:45+00:00","breadcrumb":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#primaryimage","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/06\/MSD3007-Onco-Newsroom-Teaser_LandingPage_FR.jpg","width":2646,"height":1979},{"@type":"BreadcrumbList","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/nouvelles-therapies-pour-les-tumeurs-gastro-intestinales\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mymsd.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Nouvelles th\u00e9rapies pour le traitement des tumeurs gastro-intestinales"}]},{"@type":"WebSite","@id":"https:\/\/www.mymsd.ch\/fr\/#website","url":"https:\/\/www.mymsd.ch\/fr\/","name":"MyMSD.ch FR","description":"","publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.mymsd.ch\/fr\/#organization","name":"MSD Switzerland","url":"https:\/\/www.mymsd.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2026\/11\/MSD-Logo-square.png","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2026\/11\/MSD-Logo-square.png","width":500,"height":500,"caption":"MSD Switzerland"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/5582d9c89a597dff94818e6008b86ab7","name":"MDM","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/44e333b8caf35634006075d37ca161c6c10595fef18dfb504ce1f84b93d105fe?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/44e333b8caf35634006075d37ca161c6c10595fef18dfb504ce1f84b93d105fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44e333b8caf35634006075d37ca161c6c10595fef18dfb504ce1f84b93d105fe?s=96&d=mm&r=g","caption":"MDM"},"url":"https:\/\/www.mymsd.ch\/fr\/author\/mdalmolin1\/"}]}},"_links":{"self":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/95908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/users\/202221"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/comments?post=95908"}],"version-history":[{"count":40,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/95908\/revisions"}],"predecessor-version":[{"id":103394,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/95908\/revisions\/103394"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media\/95901"}],"wp:attachment":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media?parent=95908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/categories?post=95908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tags?post=95908"},{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_audience?post=95908"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_birn_id?post=95908"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_branding?post=95908"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_businessunit?post=95908"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_campaign?post=95908"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=95908"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=95908"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=95908"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_experience?post=95908"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_indication?post=95908"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_material_intent?post=95908"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_product?post=95908"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_region?post=95908"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=95908"},{"taxonomy":"tx-therapeutic-area","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-therapeutic-area?post=95908"},{"taxonomy":"tx-product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-product?post=95908"},{"taxonomy":"tx-pathology","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-pathology?post=95908"},{"taxonomy":"tx-content-type","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-content-type?post=95908"},{"taxonomy":"tx-active-ingredient","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-active-ingredient?post=95908"},{"taxonomy":"access","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/access?post=95908"},{"taxonomy":"user_status","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_status?post=95908"},{"taxonomy":"user_role","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_role?post=95908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}